Terms: = Lung cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Prognosis
149 results:
1. Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1.
Li J; Ma X; Xu F; Yan Y; Chen W
Pharm Biol; 2024 Dec; 62(1):314-325. PubMed ID: 38571483
[TBL] [Abstract] [Full Text] [Related]
2. Exosomal long non-coding RNA MALAT1: a candidate of liquid biopsy in monitoring of Wilms' tumor.
Sharma D; Singh A; Wilson C; Swaroop P; Kumar S; Yadav DK; Jain V; Agarwala S; Husain M; Sharawat SK
Pediatr Surg Int; 2024 Feb; 40(1):57. PubMed ID: 38353772
[TBL] [Abstract] [Full Text] [Related]
3. Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors.
Cook S; Samuel V; Meyers DE; Stukalin I; Litt I; Sangha R; Morris DG; Heng DYC; Pabani A; Dean M; Navani V
JAMA Netw Open; 2024 Jan; 7(1):e2352302. PubMed ID: 38236598
[TBL] [Abstract] [Full Text] [Related]
4. Identification of tumor-suppressor genes in lung squamous cell carcinoma through integrated bioinformatics analyses.
Li H; Lei Y; Li G; Huang Y
Oncol Res; 2023; 32(1):187-197. PubMed ID: 38188687
[TBL] [Abstract] [Full Text] [Related]
5. Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial.
Desai J; Alonso G; Kim SH; Cervantes A; Karasic T; Medina L; Shacham-Shmueli E; Cosman R; Falcon A; Gort E; Guren T; Massarelli E; Miller WH; Paz-Ares L; Prenen H; Amatu A; Cremolini C; Kim TW; Moreno V; Ou SI; Passardi A; Sacher A; Santoro A; Stec R; Ulahannan S; Arbour K; Lorusso P; Luo J; Patel MR; Choi Y; Shi Z; Mandlekar S; Lin MT; Royer-Joo S; Chang J; Jun T; Dharia NV; Schutzman JL; ; Han SW
Nat Med; 2024 Jan; 30(1):271-278. PubMed ID: 38052910
[TBL] [Abstract] [Full Text] [Related]
6. Effect of initial recurrence site on the prognosis of different tissue types of non-small cell lung cancer: a retrospective cohort study.
Li Y; Liu L; You R; Li Q; Jiang Z; Pu H; Li Z; Chen X
World J Surg Oncol; 2023 Nov; 21(1):360. PubMed ID: 37986082
[TBL] [Abstract] [Full Text] [Related]
7. Classification of SLC family-related genes involved in ferroptosis predicts lung cancer prognosis and immunotherapy response.
Gao S; Gong G; Wang X; Gao X; Guo X; Luo Y; Li S; Zhang Y; Lin S
Sci Rep; 2023 Nov; 13(1):20032. PubMed ID: 37973895
[TBL] [Abstract] [Full Text] [Related]
8. Light dose effect of photodynamic therapy on growth inhibition and apoptosis induction in non-small cell lung cancer: A study in nude mouse model.
Sun W; Ma X; Wang Y; Yang G; Liao J; Cheng Y; Wang G
Photodiagnosis Photodyn Ther; 2023 Dec; 44():103865. PubMed ID: 37949389
[TBL] [Abstract] [Full Text] [Related]
9. cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors.
He S; Xia C; Li H; Cao M; Yang F; Yan X; Zhang S; Teng Y; Li Q; Chen W
Sci China Life Sci; 2024 Jan; 67(1):122-131. PubMed ID: 37755589
[TBL] [Abstract] [Full Text] [Related]
10. The tyrosine kinase inhibitor nintedanib enhances the efficacy of 90 Y-labeled B5209B radioimmunotherapy targeting ROBO1 without increased toxicity in small-cell lung cancer xenograft mice.
Fujiwara K; Tsuji AB; Sudo H; Sugyo A; Hamakubo T; Higashi T
Nucl Med Commun; 2024 Jan; 45(1):68-76. PubMed ID: 37728607
[TBL] [Abstract] [Full Text] [Related]
11. Risk factors and survival prediction of young breast cancer patients with liver metastases: a population-based study.
Pu CC; Yin L; Yan JM
Front Endocrinol (Lausanne); 2023; 14():1158759. PubMed ID: 37424855
[TBL] [Abstract] [Full Text] [Related]
12. Phase 1 trial of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced non-small cell lung cancer.
Bhalla S; Fattah FJ; Ahn C; Williams J; Macchiaroli A; Padro J; Pogue M; Dowell JE; Putnam WC; McCracken N; Micklem D; Brekken RA; Gerber DE
Lung Cancer; 2023 Aug; 182():107291. PubMed ID: 37423058
[TBL] [Abstract] [Full Text] [Related]
13. LncRNA HHIP-AS1 suppresses lung squamous cell carcinoma by stabilizing HHIP mRNA.
Hu Z; Liu Y; Tang J; Luo R; Qin J; Mo Z; Xie J; Jiang X; Wei S; Lin C
Life Sci; 2023 May; 321():121578. PubMed ID: 36958438
[TBL] [Abstract] [Full Text] [Related]
14. Poor Karnofsky performance status is not a contraindication for neurosurgical resection in patients with lung cancer brain metastases: a multicenter, retrospective PSM-IPTW cohort study.
Liang L; Wen L; Qin S; He Z; Lu J; Cui R; Jiang X; Hu H; Zhong S; Li C; Yu C; Xie Y; Wang Z; Duan H; Mou Y
J Neurooncol; 2023 Apr; 162(2):327-335. PubMed ID: 36940052
[TBL] [Abstract] [Full Text] [Related]
15. Clinical profiles and intraoperative identification of complex glands in stage I lung adenocarcinoma.
Ding Q; Chen D; Shen S; Wang W; Chen L; Duan S; Chen Y
Eur J Cardiothorac Surg; 2023 Mar; 63(3):. PubMed ID: 36825852
[TBL] [Abstract] [Full Text] [Related]
16. [Soft tissue reconstruction strategy for sacral tumor resection].
Sha M; Ding ZQ; Hong HS; Nie K; Lin XC; Shao JC; Song W; Kang LQ
Zhonghua Wai Ke Za Zhi; 2022 Dec; 60(12):1085-1092. PubMed ID: 36480876
[No Abstract] [Full Text] [Related]
17. Successful control of intestinal bleeding from metastasis of pulmonary pleomorphic carcinoma with pembrolizumab: A case report.
Ikushima H; Asaga R; Sakatani T; Masuda Y; Morikawa T; Usui K
Medicine (Baltimore); 2022 Oct; 101(42):e31220. PubMed ID: 36281091
[TBL] [Abstract] [Full Text] [Related]
18. Pathological Stage N1 Limited-Stage Small-Cell lung cancer Patients Can Benefit From Surgical Resection.
Yu L; Xu J; Qiao R; Han B; Zhong H; Zhong R
Clin Lung Cancer; 2023 Jan; 24(1):e1-e8. PubMed ID: 36085281
[TBL] [Abstract] [Full Text] [Related]
19. Current cancer burden in China: epidemiology, etiology, and prevention.
Maomao C; He L; Dianqin S; Siyi H; Xinxin Y; Fan Y; Shaoli Z; Changfa X; Lin L; Ji P; Wanqing C
Cancer Biol Med; 2022 Aug; 19(8):1121-38. PubMed ID: 36069534
[TBL] [Abstract] [Full Text] [Related]
20. HEG1 as a novel potential biomarker for the prognosis of lung adenocarcinoma.
Zou X; Zhang Y; Wang N; Shi J; Li Q; Hao W; Zhu W; Han W
Cancer Med; 2023 Feb; 12(3):3288-3298. PubMed ID: 35950222
[TBL] [Abstract] [Full Text] [Related]
[Next]
